| Literature DB >> 27853893 |
Katsuhiro Takeda1, Naoko Tokunaga2, Yusuke Aida2, Mikihito Kajiya2, Kazuhisa Ouhara2, Shinya Sasaki2, Noriyoshi Mizuno2, Tsuyoshi Fujita2, Hidemi Kurihara2.
Abstract
The aim of this study was to examine the anti-inflammatory effect of brain-derived neurotrophic factor (BDNF) on human dental pulp cells (HDPCs) and identify the intracellular signaling pathway involved. We investigated the effect of BDNF (50 ng/ml) on interleukin (IL)-6 and IL-8 expression in peptidoglycan (PGN)-treated HDPCs. An inhibition assay was performed with MAPK or NF-κB inhibitors to determine the possible signaling pathway. IL-6 and IL-8 mRNA, IL-6 and IL-8 protein, and phosphorylated p38 kinase activity were determined using real-time PCR, ELISA, and Western blot analysis, respectively. BDNF significantly attenuated PGN-induced IL-6 and IL-8 mRNA and protein levels in HDPCs. A p38 inhibitor also inhibited IL-6 and IL-8 mRNA transcription. PGN stimulated phosphorylated p38 kinase activity in HDPCs, which was inhibited by BDNF. Suppression of phosphorylated p38 kinase activity by BDNF in HDPCs inhibited increased IL-6 and IL-8 expression induced by PGN. Our findings suggest that BDNF regulates intracellular signaling molecule activities to exert its anti-inflammatory effect.Entities:
Keywords: brain-derived neurotrophic factor; endodontic treatment; peptidoglycan; pulp cells
Mesh:
Substances:
Year: 2017 PMID: 27853893 DOI: 10.1007/s10753-016-0474-4
Source DB: PubMed Journal: Inflammation ISSN: 0360-3997 Impact factor: 4.092